VAERS reports by lot

Merck HPV lot 1061U: VAERS reports

88 VAERS reports list lot 1061U as a Merck HPV vaccine, received between 2007-08-24 and 2012-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
88
Reports
57%
Marked serious
0
With a death outcome
27
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological9120%
General / Systemic (non-local)8218%
Gastrointestinal6314%
Cardiac / Cardiovascular5612%
Injection-site / Local reaction358%
Dermatological (non-injection-site)327%
Respiratory286%
Musculoskeletal276%
Allergic / Anaphylactic235%
Psychiatric / Neuropsychiatric82%
Autoimmune / Immune-mediated61%
Thrombotic / Hematological51%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York9
Pennsylvania6
Virginia6
California5
Texas5
Minnesota4
New Jersey4
Massachusetts3
Michigan3
Tennessee3
North Carolina3
Iowa3

Reports by month received

2007-081
2007-0912
2007-1014
2007-119
2007-123
2008-014
2008-023
2008-034
2008-045
2008-053
2008-061
2008-074
2008-086
2008-091
2008-101
2008-123
2009-023
2009-032
2009-041
2009-051
2009-061
2009-081
2009-091
2009-121
2010-071
2010-091
2012-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.